Atlas Trials

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Clinical trial NCT00001810 · COMPLETED

Trial details

NCT number
NCT00001810
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AspergillosisCandidiasisFungemiaMycoses
Start date
1999-04-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.